- Report
- March 2024
- 194 Pages
Global
From €3242EUR$3,374USD£2,788GBP
€3602EUR$3,749USD£3,097GBP
- Report
- January 2024
- 175 Pages
Global
From €4804EUR$5,000USD£4,131GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1441EUR$1,500USD£1,239GBP
- Report
- February 2021
- 500 Pages
United States
From €2306EUR$2,400USD£1,983GBP
- Report
- February 2024
- 70 Pages
India
From €4564EUR$4,750USD£3,924GBP
- Report
- November 2020
- 225 Pages
Global
From €10565EUR$10,995USD£9,084GBP
- Report
- May 2024
- 50 Pages
Global
From €2546EUR$2,650USD£2,189GBP
Bromocriptine is a drug used to treat endocrine and metabolic disorders. It is a dopamine agonist, meaning it works by activating dopamine receptors in the body. It is used to treat conditions such as acromegaly, hyperprolactinemia, and type 2 diabetes. It is also used to treat Parkinson's disease and other neurological disorders. Bromocriptine is available in both oral and injectable forms.
Bromocriptine is a widely used drug in the endocrine and metabolic disorders market. It is used to treat a variety of conditions, including acromegaly, hyperprolactinemia, and type 2 diabetes. It is also used to treat Parkinson's disease and other neurological disorders.
Some companies in the Bromocriptine market include Novartis, Pfizer, Merck, and Sanofi. Show Less Read more